Entrada Therapeutics
TRDA
TRDA
47 hedge funds and large institutions have $334M invested in Entrada Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
47
Holders Change
+14
Holders Change %
+42.42%
% of All Funds
0.76%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
17
Increased
16
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.51M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$12.4M |
| 3 |
3
Citigroup
New York
|
$690K |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$40.8M |
| 5 |
5
BlackRock
New York
|
$2.54M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 28 | +28 | New |
|